Innovative MedTech (Innovative MedTech) EBITDA Margin % : -186.59% (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Innovative MedTech EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Innovative MedTech's EBITDA for the three months ended in Mar. 2024 was $-0.85 Mil. Innovative MedTech's Revenue for the three months ended in Mar. 2024 was $0.46 Mil. Therefore, Innovative MedTech's EBITDA margin for the quarter that ended in Mar. 2024 was -186.59%.

Innovative MedTech EBITDA Margin % Historical Data

The historical data trend for Innovative MedTech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative MedTech EBITDA Margin % Chart

Innovative MedTech Annual Data

Trend

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Jun20

Jun21

Jun22

Jun23

EBITDA Margin %

Get a 7-Day Free Trial

-883.38

-1,371.19

-195.36

Innovative MedTech Quarterly Data
	Jan14	Apr14	Jul14	Oct14	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBITDA Margin %	Get a 7-Day Free Trial															-158.07	-165.24	-19.54	-28.41	-186.59

Competitive Comparison of Innovative MedTech's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Innovative MedTech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative MedTech's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innovative MedTech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Innovative MedTech's EBITDA Margin % falls into.

Innovative MedTech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Innovative MedTech's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-3.37	/	1.725
	=	-195.36 %

Innovative MedTech's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.849	/	0.455
	=	-186.59 %

Innovative MedTech (OTCPK:IMTH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Innovative MedTech EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Innovative MedTech's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative MedTech (Innovative MedTech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innovative MedTech Inc (OTCPK:IMTH) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2310 York Street, Suite 200, Blue Island, IL, USA, 60406

Website

https://www.innovativemedtech.com

Innovative MedTech Inc is a provider of health and wellness services. It develops, manufactures, and sells a variety of medical devices and supplies, including blood collection and infusion products, surgical instruments, and wound care products. The company operates in two divisions: the RX Vitality digital wallet and health care app.

Executives

Merle Griff	officer: Chief Executive Officer	2310 YORK ST, SUITE 200, BLUE ISLAND IL 60406
Eddie Dovner	10 percent owner	70 SE 4TH AVE, DELRAY BEACH FL 33483
Charles Everhardt	director, 10 percent owner, other: Chairman of the Board	2310 YORK ST, STE 200, BLUE ISLAND IL 60406
Arthur Friedman	10 percent owner	280 MADISON AVE #1007, NEW YORK NY 10016
Marcia Roberts	10 percent owner	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Michael Jordan Friedman	director, 10 percent owner, officer: President & CEO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Illuminate, Inc.	10 percent owner	881 KENNEDY BLVD., JERSEY CITL NJ 07002
A William Bodine	director, officer: CFO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Dominick M Cingari	director, officer: COO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Jay Odintz	director	280 MADISON AVENUE, NEW YORK NY 10016
Vincent L Verdiramo	director, officer: President	3163 KENNEDY BLVD, JERSEY CITY NJ 07306